EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo iD

Advanced Materials · 2026-09 · 38 (51)

DOI: 10.1002/adma.202510355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 27.08.2025. Verfasst von Guillermo Landa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, 50009, Spain. Hauptthemen laut MEDLINE: Nanostructures, Bacteria, Drug Delivery Systems, Anti-Bacterial Agents. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Ministry of Science, Innovation and Universities, Severo Ochoa Programme for Centers of Excellence in R&D, Aragon Government for the grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteria exhibit adaptive phenotypic traits that confer resistance to host defenses and antimicrobial therapies. In response to the global threat of antimicrobial resistance, bacteria‐responsive nanostructured drug delivery systems have emerged as a promising alternative to conventional broad‐spectrum antimicrobials. These systems release therapeutics selectively in response to bacterial presence or to their secreted enzymes, toxins, antigens, or extracellular biomarkers, enabling precise activation at infection sites while minimizing off‐target effects. Bacterial components such as membrane proteins, signaling molecules, biofilm‐associated glycolipids, and enzymes (e.g., lipase, hyaluronidase) serve as triggers for these smart carriers. Exopolysaccharides are also commonly targeted using nanocarriers with complementary recognition elements. Such systems are often surface‐modified or loaded with antimicrobials for on‐demand release. Benefits include enhanced selectivity, reduced side effects, improved biofilm penetration, higher intracellular accumulation, and potential for personalized therapy. A variety of materials—including lipid‐based carriers, metal nanoparticles, polymer nanoparticles, and inorganic nanomaterials—have been engineered to release antimicrobials only in the presence of pathogenic bacteria, often offering dual therapeutic effects (e.g., anti‐inflammatory). Furthermore, many platforms integrate multiple antimicrobial mechanisms, reducing the likelihood of resistance development. This review highlights recent preclinical studies validating bacteria‐responsive nanosystems and underscores their advantages over passive drug delivery and conventional free antimicrobials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanostructuresBacteriaDrug Delivery SystemsAnti-Bacterial AgentsAnti-Infective AgentsHumansAnimalsDrug CarriersBiofilms

Stichwörter der Autor:innen

bacterial infectionsbiofilmdrug delivery systemsnanostructured materialsquorum sensingtargeted antimicrobial treatments

Substanzen

Drug CarriersAnti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, 50009, Spain.
  • Department of Chemical and Environmental Engineering, University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, Zaragoza, 50018, Spain.
  • Health Research Institute Aragon (IIS Aragon), Zaragoza, 50009, Spain.
  • Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Facultad de Medicina-Edificio A, University of Zaragoza, C/Domingo Miral, S/N, Zaragoza, 50009, Spain.

ORCID-Profile: Manuel Arruebo

Förderung

  • Spanish Ministry of Science, Innovation and Universities
  • Severo Ochoa Programme for Centers of Excellence in R&D
  • Aragon Government for the grant
  • Instituto de Salud Carlos III (Spain; Fortalece Call, grant number
  • Miguel Servet Program

Zitieren

APA

Landa, G., Mendoza, G., Irusta, S., & Arruebo, M. (2026). Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy. Advanced Materials, 38(51). https://doi.org/10.1002/adma.202510355

Vancouver

Landa G, Mendoza G, Irusta S, Arruebo M. Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy. Advanced Materials. 2026;38(51). doi:10.1002/adma.202510355

BibTeX
@article{Landa2026,
  author = {Landa, Guillermo and Mendoza, Gracia and Irusta, Silvia and Arruebo, Manuel},
  title = {Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {51},
  doi = {10.1002/adma.202510355}
}
Kostenlos starten →